Pharmacokinetics and Tissue Distribution Study for 2‐(2‐Fluorophenyl)‐5‐Phenyl‐7‐Alkoxy‐ [1,2,4]Triazole[1,5‐a]Pyrimidine Antiepileptic Compounds in Rats
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Han Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China. Hauptthemen laut MEDLINE: Anticonvulsants, Pyrimidines, Triazoles. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Research on Key Technologies for Multi-Dimensional Microbial Culture Support & Product Industrialization.
Abstract (Originalsprache)
The development of novel active molecules with a clear target has always been an urgent need for the treatment of epilepsy. Previously, we reported 2‐(2‐fluorophenyl)‐5‐phenyl‐7‐propyl‐[1,2,4]triazolo[1,5‐a]pyrimidine ( 10C ) as a selective and positive modulator of GABA A receptors, which exhibited excellent antiepileptic activity in mice with an ED 50 value of 8.51 mg/kg. However, the pharmacokinetics (PK) profiles of this compound remain unclear. In this study, 10C and four analogs ( 10A , 10B , 10D , and 10E ) as well as deuterated 10C were synthesized with high efficiency under optimized reaction conditions, and deuterated 10C was employed as an internal standard. The concentrations of the five compounds in rat plasma and of 10C in tissue homogenate were assayed using a liquid chromatography–tandem mass spectrometry (LC‐MS/MS) method. The results indicated that, compared to the other four analogs, 10C exhibited the highest drug concentration in rat plasma at the same dosage, which provides a good explanation for its superior antiepileptic activity compared to the other four analogs. Following intraperitoneal injection, 10C displayed favorable pharmacokinetic characteristics ( F = 41%) and excellent brain penetration potency (B/ P = 1.9). Overall, compound 10C is a promising lead for the research and development of new small‐molecule therapeutics for epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China.
- Qingdao Haier Biomedical Co, Ltd, Qingdao, China.
- Department of Pharmacy, Affiliated Hospital of Qingdao University, Qingdao, China.
ORCID-Profile: Feng Su, Longjiang Huang
Förderung
- Natural Science Foundation of Shandong Province
- Research on Key Technologies for Multi-Dimensional Microbial Culture Support & Product Industrialization
Zitieren
APA
Liang, H., Guo, R., Zhou, Y., Lv, C., Guo, C., Su, F., Dong, Q., Huang, L., & Xu, W. (2025). Pharmacokinetics and Tissue Distribution Study for 2‐(2‐Fluorophenyl)‐5‐Phenyl‐7‐Alkoxy‐ [1,2,4]Triazole[1,5‐a]Pyrimidine Antiepileptic Compounds in Rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.70088
Vancouver
Liang H, Guo R, Zhou Y, Lv C, Guo C, Su F, et al. Pharmacokinetics and Tissue Distribution Study for 2‐(2‐Fluorophenyl)‐5‐Phenyl‐7‐Alkoxy‐ [1,2,4]Triazole[1,5‐a]Pyrimidine Antiepileptic Compounds in Rats. Biomedical Chromatography. 2025. doi:10.1002/bmc.70088
BibTeX
@article{Liang2025,
author = {Liang, Han and Guo, Ranran and Zhou, Yuxi and Lv, Cui and Guo, Chuanlong and Su, Feng and Dong, Qingkun and Huang, Longjiang and Xu, Wen},
title = {Pharmacokinetics and Tissue Distribution Study for 2‐(2‐Fluorophenyl)‐5‐Phenyl‐7‐Alkoxy‐ [1,2,4]Triazole[1,5‐a]Pyrimidine Antiepileptic Compounds in Rats},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70088}
}
EUVIMED